Comparison of diagnostic performances of ten different immunoassays detecting anti-CCHFV IgM and IgG antibodies from acute to subsided phases of Crimean-Congo hemorrhagic fever.

Crimean-Congo Hemorrhagic Fever Virus (CCHFV) is a geographically widespread tick-borne arbovirus that has been recognized by the WHO as an emerging pathogen needing urgent attention to ensure preparedness for potential outbreaks. Therefore, availability of accurate diagnostic tools for identificati...

Full description

Saved in:
Bibliographic Details
Main Authors: Petra Emmerich, Ronald von Possel, Christina Deschermeier, Salih Ahmeti, Lindita Berisha, Bahrije Halili, Xhevat Jakupi, Kurtesh Sherifi, Claudia Messing, Viola Borchardt-Lohölter
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-03-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0009280&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849329914621198336
author Petra Emmerich
Ronald von Possel
Christina Deschermeier
Salih Ahmeti
Lindita Berisha
Bahrije Halili
Xhevat Jakupi
Kurtesh Sherifi
Claudia Messing
Viola Borchardt-Lohölter
author_facet Petra Emmerich
Ronald von Possel
Christina Deschermeier
Salih Ahmeti
Lindita Berisha
Bahrije Halili
Xhevat Jakupi
Kurtesh Sherifi
Claudia Messing
Viola Borchardt-Lohölter
author_sort Petra Emmerich
collection DOAJ
description Crimean-Congo Hemorrhagic Fever Virus (CCHFV) is a geographically widespread tick-borne arbovirus that has been recognized by the WHO as an emerging pathogen needing urgent attention to ensure preparedness for potential outbreaks. Therefore, availability of accurate diagnostic tools for identification of acute cases is necessary. A panel comprising 121 sequential serum samples collected during acute, convalescent and subsided phase of PCR-proven CCHFV infection from 16 Kosovar patients was used to assess sensitivity. Serum samples from 60 healthy Kosovar blood donors were used to assess specificity. All samples were tested with two IgM/IgG immunofluorescence assays (IFA) from BNITM, the CCHFV Mosaic 2 IgG and IgM indirect immunofluorescence tests (IIFT) from EUROIMMUN, two BlackBox ELISAs for the detection of CCHFV-specific IgM and IgG antibodies (BNITM), two Anti-CCHFV ELISAs IgM and IgG from EUROIMMUN using recombinant structural proteins of CCHFV antigens, and two ELISAs from Vector-Best (IgM: μ-capture ELISA, IgG: indirect ELISA using immobilized CCHFV antigen). Diagnostic performances were compared between methods using sensitivity, specificity, concordance and degree of agreement with particular focus on the phase of the infection. In early and convalescent phases of infection, the sensitivities for detecting specific IgG antibodies differed for the ELISA test. The BlackBox IgG ELISA yielded the highest, followed by the EUROIMMUN IgG ELISA and finally the VectorBest IgG ELISA with the lowest sensitivities. In the subsided phase, the VectorBest IgM ELISA detected a high rate of samples that were positive for anti-CCHFV IgM antibodies. Both test systems based on immunofluorescence showed an identical sensitivity for detection of anti-CCHFV IgM antibodies in acute and convalescent phases of infection. Available serological test systems detect anti-CCHFV IgM and IgG antibodies accurately, but their diagnostic performances vary with respect to the phase of the infection.
format Article
id doaj-art-503af19af5dc4f4fa9e71ef5b2e478c4
institution Kabale University
issn 1935-2727
1935-2735
language English
publishDate 2021-03-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj-art-503af19af5dc4f4fa9e71ef5b2e478c42025-08-20T03:47:07ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352021-03-01153e000928010.1371/journal.pntd.0009280Comparison of diagnostic performances of ten different immunoassays detecting anti-CCHFV IgM and IgG antibodies from acute to subsided phases of Crimean-Congo hemorrhagic fever.Petra EmmerichRonald von PosselChristina DeschermeierSalih AhmetiLindita BerishaBahrije HaliliXhevat JakupiKurtesh SherifiClaudia MessingViola Borchardt-LohölterCrimean-Congo Hemorrhagic Fever Virus (CCHFV) is a geographically widespread tick-borne arbovirus that has been recognized by the WHO as an emerging pathogen needing urgent attention to ensure preparedness for potential outbreaks. Therefore, availability of accurate diagnostic tools for identification of acute cases is necessary. A panel comprising 121 sequential serum samples collected during acute, convalescent and subsided phase of PCR-proven CCHFV infection from 16 Kosovar patients was used to assess sensitivity. Serum samples from 60 healthy Kosovar blood donors were used to assess specificity. All samples were tested with two IgM/IgG immunofluorescence assays (IFA) from BNITM, the CCHFV Mosaic 2 IgG and IgM indirect immunofluorescence tests (IIFT) from EUROIMMUN, two BlackBox ELISAs for the detection of CCHFV-specific IgM and IgG antibodies (BNITM), two Anti-CCHFV ELISAs IgM and IgG from EUROIMMUN using recombinant structural proteins of CCHFV antigens, and two ELISAs from Vector-Best (IgM: μ-capture ELISA, IgG: indirect ELISA using immobilized CCHFV antigen). Diagnostic performances were compared between methods using sensitivity, specificity, concordance and degree of agreement with particular focus on the phase of the infection. In early and convalescent phases of infection, the sensitivities for detecting specific IgG antibodies differed for the ELISA test. The BlackBox IgG ELISA yielded the highest, followed by the EUROIMMUN IgG ELISA and finally the VectorBest IgG ELISA with the lowest sensitivities. In the subsided phase, the VectorBest IgM ELISA detected a high rate of samples that were positive for anti-CCHFV IgM antibodies. Both test systems based on immunofluorescence showed an identical sensitivity for detection of anti-CCHFV IgM antibodies in acute and convalescent phases of infection. Available serological test systems detect anti-CCHFV IgM and IgG antibodies accurately, but their diagnostic performances vary with respect to the phase of the infection.https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0009280&type=printable
spellingShingle Petra Emmerich
Ronald von Possel
Christina Deschermeier
Salih Ahmeti
Lindita Berisha
Bahrije Halili
Xhevat Jakupi
Kurtesh Sherifi
Claudia Messing
Viola Borchardt-Lohölter
Comparison of diagnostic performances of ten different immunoassays detecting anti-CCHFV IgM and IgG antibodies from acute to subsided phases of Crimean-Congo hemorrhagic fever.
PLoS Neglected Tropical Diseases
title Comparison of diagnostic performances of ten different immunoassays detecting anti-CCHFV IgM and IgG antibodies from acute to subsided phases of Crimean-Congo hemorrhagic fever.
title_full Comparison of diagnostic performances of ten different immunoassays detecting anti-CCHFV IgM and IgG antibodies from acute to subsided phases of Crimean-Congo hemorrhagic fever.
title_fullStr Comparison of diagnostic performances of ten different immunoassays detecting anti-CCHFV IgM and IgG antibodies from acute to subsided phases of Crimean-Congo hemorrhagic fever.
title_full_unstemmed Comparison of diagnostic performances of ten different immunoassays detecting anti-CCHFV IgM and IgG antibodies from acute to subsided phases of Crimean-Congo hemorrhagic fever.
title_short Comparison of diagnostic performances of ten different immunoassays detecting anti-CCHFV IgM and IgG antibodies from acute to subsided phases of Crimean-Congo hemorrhagic fever.
title_sort comparison of diagnostic performances of ten different immunoassays detecting anti cchfv igm and igg antibodies from acute to subsided phases of crimean congo hemorrhagic fever
url https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0009280&type=printable
work_keys_str_mv AT petraemmerich comparisonofdiagnosticperformancesoftendifferentimmunoassaysdetectinganticchfvigmandiggantibodiesfromacutetosubsidedphasesofcrimeancongohemorrhagicfever
AT ronaldvonpossel comparisonofdiagnosticperformancesoftendifferentimmunoassaysdetectinganticchfvigmandiggantibodiesfromacutetosubsidedphasesofcrimeancongohemorrhagicfever
AT christinadeschermeier comparisonofdiagnosticperformancesoftendifferentimmunoassaysdetectinganticchfvigmandiggantibodiesfromacutetosubsidedphasesofcrimeancongohemorrhagicfever
AT salihahmeti comparisonofdiagnosticperformancesoftendifferentimmunoassaysdetectinganticchfvigmandiggantibodiesfromacutetosubsidedphasesofcrimeancongohemorrhagicfever
AT linditaberisha comparisonofdiagnosticperformancesoftendifferentimmunoassaysdetectinganticchfvigmandiggantibodiesfromacutetosubsidedphasesofcrimeancongohemorrhagicfever
AT bahrijehalili comparisonofdiagnosticperformancesoftendifferentimmunoassaysdetectinganticchfvigmandiggantibodiesfromacutetosubsidedphasesofcrimeancongohemorrhagicfever
AT xhevatjakupi comparisonofdiagnosticperformancesoftendifferentimmunoassaysdetectinganticchfvigmandiggantibodiesfromacutetosubsidedphasesofcrimeancongohemorrhagicfever
AT kurteshsherifi comparisonofdiagnosticperformancesoftendifferentimmunoassaysdetectinganticchfvigmandiggantibodiesfromacutetosubsidedphasesofcrimeancongohemorrhagicfever
AT claudiamessing comparisonofdiagnosticperformancesoftendifferentimmunoassaysdetectinganticchfvigmandiggantibodiesfromacutetosubsidedphasesofcrimeancongohemorrhagicfever
AT violaborchardtloholter comparisonofdiagnosticperformancesoftendifferentimmunoassaysdetectinganticchfvigmandiggantibodiesfromacutetosubsidedphasesofcrimeancongohemorrhagicfever